Глобальна гаряча лінія для українських пацієнтів-біженців, які беруть участь у клінічному випробуванні Amgen. Натисніть тут для отримання додаткової інформації.
Глобальная горячая линия для украинских пациентов-беженцев, участвующих в клиническом исследовании Amgen. Для получения дополнительной информации нажмите здесь.
Science & Innovation 06.23.2022
Join host Ray Deshaies, Amgen’s senior vice president of Global Research, in conversations with leading scientific experts about the potential to enhance the speed and efficiency of biologics discovery.
Patients 06.22.2022
Responsibility 06.20.2022
People & Culture 06.15.2022
Read David Henze’s story of international adoption and how Amgen’s flexibility helped support his growing and evolving family.
Responsibility 06.15.2022
June is Pride month and Amgen is flying the progress pride flag at sites around the world – a visible sign of the company’s commitment to being an ally to our LGBTQ+ colleagues, and reinforcing that our differences lead to better science.
Science & Innovation 06.14.2022
Celebrating its 25th anniversary, deCODE genetics, an Amgen subsidiary, is studying the impact of human diversity on disease, improving drug discovery and development.
PRESS RELEASE
Amgen is a pioneer in the science of using living cells to make biologic medicines.
Amgen’s medicines treat serious illnesses and typically address diseases with a limited number of treatment options.
Making a positive difference in the world is at the heart of what we do at Amgen—and it goes beyond making vital medicines.
Amgen is a pioneer in the science of using living cells to making biologic medicines, leading and guiding the biotech industry.
Encounter opportunities both new and undiscovered, as we embrace leading-edge technologies, invest in our talents, and maximize our potential.
